Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy

(MedPage Today) — Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single drug, a small randomized trial showed.
The pathologic tumor response (pTR) rate increased from 41…

Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/114724

Author :

Publish date : 2025-03-18 21:35:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31

Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy

Young Patient Dies After Receiving New Gene Therapy for Duchenne Muscular Dystrophy

Flurry of worry over benefit changes

Related Posts

Flurry of worry over benefit changes

Young Patient Dies After Receiving New Gene Therapy for Duchenne Muscular Dystrophy

Texas Midwife Accused by State’s Attorney General of Providing Illegal Abortions

Transplant Doc’s Future in U.S. Uncertain Following Her Deportation to Lebanon

This Vaccine Researcher Was Caught in the NIH Funding Cut Crossfire

Snubbed Vaccine Committee Members Lament FDA’s Flu Shot Actions

Flurry of worry over benefit changes

Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy

Young Patient Dies After Receiving New Gene Therapy for Duchenne Muscular Dystrophy

Texas Midwife Accused by State’s Attorney General of Providing Illegal Abortions

Transplant Doc’s Future in U.S. Uncertain Following Her Deportation to Lebanon

This Vaccine Researcher Was Caught in the NIH Funding Cut Crossfire

Snubbed Vaccine Committee Members Lament FDA’s Flu Shot Actions

Investigational ADC Shows Promise in Advanced Endometrial Cancer

Categories

Archives